CD30L Antibodies

Santa Cruz Biotechnology provides a broad selection of CD30L monoclonal antibodies for advanced research in immunology and cell signaling. CD30L monoclonal antibodies perform effectively in various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD30L, also known as CD153, is a member of the tumor necrosis factor (TNF) superfamily and plays a crucial role in regulating immune responses, particularly in T-cell activation and differentiation. The interaction between CD30L and CD30, a receptor expressed on activated T cells, is vital for promoting cell survival and proliferation. CD30L serves as an important target in studies related to autoimmune diseases and cancer immunotherapy. Understanding CD30L function is essential for developing therapeutic strategies aimed at modulating immune responses. Researchers investigating CD30L can explore its role in various cellular pathways and signaling mechanisms. CD30L research contributes significantly to understanding T-cell development and immune system regulation. Santa Cruz Biotechnology monoclonal antibodies for CD30L support researchers worldwide in advancing scientific knowledge and developing potential therapeutic applications.